911 related articles for article (PubMed ID: 16014651)
1. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
Halliday GM; Macdonald V; Henderson JM
Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
[TBL] [Abstract][Full Text] [Related]
2. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease.
MacDonald V; Halliday GM
Mov Disord; 2002 Nov; 17(6):1166-73. PubMed ID: 12465053
[TBL] [Abstract][Full Text] [Related]
3. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
4. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
[TBL] [Abstract][Full Text] [Related]
5. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
6. Lewy bodies in progressive supranuclear palsy.
Mori H; Oda M; Komori T; Arai N; Takanashi M; Mizutani T; Hirai S; Mizuno Y
Acta Neuropathol; 2002 Sep; 104(3):273-8. PubMed ID: 12172913
[TBL] [Abstract][Full Text] [Related]
7. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.
Cordato NJ; Halliday GM; Harding AJ; Hely MA; Morris JG
Ann Neurol; 2000 Jun; 47(6):718-28. PubMed ID: 10852537
[TBL] [Abstract][Full Text] [Related]
8. Intralaminar nuclei of the thalamus in Lewy body diseases.
Brooks D; Halliday GM
Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
[TBL] [Abstract][Full Text] [Related]
9. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
[TBL] [Abstract][Full Text] [Related]
10. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
[TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
12. Co-occurrence of Parkinson's disease with progressive supranuclear palsy.
Judkins AR; Forman MS; Uryu K; Hinkle DA; Asbury AK; Lee VM; Trojanowski JQ
Acta Neuropathol; 2002 May; 103(5):526-30. PubMed ID: 11935271
[TBL] [Abstract][Full Text] [Related]
13. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
Henderson JM; Carpenter K; Cartwright H; Halliday GM
Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
[TBL] [Abstract][Full Text] [Related]
14. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration.
Piao YS; Hayashi S; Wakabayashi K; Kakita A; Aida I; Yamada M; Takahashi H
Acta Neuropathol; 2002 May; 103(5):469-74. PubMed ID: 11935262
[TBL] [Abstract][Full Text] [Related]
15. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
Hardman CD; Halliday GM
Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
[TBL] [Abstract][Full Text] [Related]
16. Thalamic changes in Parkinson's disease.
Halliday GM
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S152-5. PubMed ID: 20082979
[TBL] [Abstract][Full Text] [Related]
17. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration.
Bergeron C; Pollanen MS; Weyer L; Lang AE
J Neuropathol Exp Neurol; 1997 Jun; 56(6):726-34. PubMed ID: 9184663
[TBL] [Abstract][Full Text] [Related]
18. Heredity in Parkinson's disease: new findings.
Lev N; Melamed E
Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
[TBL] [Abstract][Full Text] [Related]
19. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
20. Functional anatomy of thalamus and basal ganglia.
Herrero MT; Barcia C; Navarro JM
Childs Nerv Syst; 2002 Aug; 18(8):386-404. PubMed ID: 12192499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
